Published in Lancet on May 20, 1978
Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78
Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed (2002) 1.09
Recognising and preventing Duchenne muscular dystrophy. Br Med J (Clin Res Ed) (1983) 1.05
A genetic study of Duchenne muscular dystrophy in West Midlands. J Med Genet (1981) 0.97
Evidence based case report: Assessing developmental delay. BMJ (2001) 0.97
Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapies. Clin Biochem Rev (2011) 0.83
Screening for Duchenne muscular dystrophy. Arch Dis Child (1994) 0.75
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (1990) 11.92
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Functional domains of the human estrogen receptor. Cell (1987) 6.52
Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J (1986) 6.08
Nuclear receptors enhance our understanding of transcription regulation. Trends Genet (1988) 5.95
Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature (1987) 5.47
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88
Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A (1985) 4.58
The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J (1986) 4.47
The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell (1988) 4.22
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell (1988) 4.17
The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J (1992) 3.92
Screening for prostate cancer. Cochrane Database Syst Rev (2006) 3.46
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Genomic organization of the human oestrogen receptor gene. EMBO J (1988) 2.65
Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis (2004) 2.54
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50
A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city. Int J Epidemiol (1991) 2.49
The 40K activity of one gram of potassium. Phys Med Biol (1997) 2.48
Effect of tumour necrosis factor on cultured human melanoma cells. Nature (1975) 2.46
Partial purification of a serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1976) 2.42
A superfamily of potentially oncogenic hormone receptors. Nature (1987) 2.40
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
Tuberous sclerosis: a genetic study. J Neurol Neurosurg Psychiatry (1969) 2.35
Early recognition of heterozygotes for the gene for dystrophia myotonica. J Neurol Neurosurg Psychiatry (1970) 2.30
A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet (1993) 2.23
Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev (2003) 2.23
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health (1993) 2.17
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
A study of retinitis pigmentosa in the City of Birmingham. I Prevalence. J Med Genet (1984) 2.15
Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy (2013) 2.10
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
'Curing' empty follicle syndrome. Hum Reprod (1997) 2.01
Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med (1994) 1.98
Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain (2006) 1.95
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
Evaluation of a postal screening questionnaire to identify the physically disabled. Int Rehabil Med (1980) 1.94
Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature (1968) 1.89
Triazolam as a substance of abuse among injecting drug users. Br J Addict (1992) 1.86
Clinical features and classification of the muscular dystrophies. Br Med Bull (1980) 1.82
Auditory sensitivity of the monkey. Science (1966) 1.81
A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology. J Med Genet (1985) 1.80
Natural history of idiopathic torsion dystonia. Adv Neurol (1976) 1.79
PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun (1993) 1.79
Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax (1987) 1.77
Knowledge of and attitude toward patient confidentiality within three family medicine teaching units. Acad Med (1998) 1.77
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol (1992) 1.76
Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet (1990) 1.76
The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO J (1989) 1.75
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Screening for disability in the inner city. J Epidemiol Community Health (1981) 1.72
Human serum beta-glucuronidase; its measurement and some of its properties. Clin Chim Acta (1967) 1.71
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol (1993) 1.69
Retracted Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab. Br J Cancer (2010) 1.69
Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr (2001) 1.67
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. J Clin Oncol (1994) 1.67
The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol Cell Biol (1996) 1.66
Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg (2001) 1.65
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
Benign spinal muscular atrophy arising in childhood and adolescence. J Neurol Sci (1968) 1.57
Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. Clin Nutr (2000) 1.56
Pre-operative education for hip or knee replacement. Cochrane Database Syst Rev (2004) 1.53
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52
Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection. J Neurol Neurosurg Psychiatry (1968) 1.50
Prevalence and incidence of Becker muscular dystrophy. Lancet (1991) 1.50
A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A (1995) 1.49
Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48
A clinical and genetic study of chronic proximal spinal muscular atrophy. Brain (1975) 1.48
Usher syndrome in the city of Birmingham--prevalence and clinical classification. Br J Ophthalmol (1997) 1.46
Impaired T cell proliferation in acute dengue infection. J Immunol (1999) 1.46
Human fertilization with round and elongated spermatids. Hum Reprod (1997) 1.44
A study of retinitis pigmentosa in the City of Birmingham. II Clinical and genetic heterogeneity. J Med Genet (1984) 1.44
Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol (1977) 1.44
Cellular and humoral responses to measles in subacute sclerosing panencephalitis. Lancet (1969) 1.44
Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J (1998) 1.44
Two cases of cryptococcal meningitis, one treated with 5-fluorocytosine. Br Med J (1969) 1.43
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet (1999) 1.42
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. J Clin Oncol (1998) 1.42
Conduct disorder in girls: a review of the literature. Clin Child Fam Psychol Rev (1999) 1.40
Diaphragmatic paralysis due to spinal muscular atrophy. An unrecognised cause of respiratory failure in infancy? Arch Dis Child (1985) 1.40
Regulation of calmodulin gene expression by insulin is both transcriptional and post-transcriptional. J Lab Clin Med (1994) 1.39
Missed prenatal diagnosis of fragile-X syndrome. Prenat Diagn (1989) 1.39
Surgery for rotator cuff disease. Cochrane Database Syst Rev (2008) 1.39
The CNS role: evolution within a shared governance environment. Clin Nurse Spec (1993) 1.38
A genetic study of torsion dystonia. J Med Genet (1975) 1.37
Regulation of apoptosis by BH3 domains in a cell-free system. Curr Biol (1997) 1.37
The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol (1993) 1.37
Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36
The association between traumatic experience, paranoia and hallucinations: a test of the predictions of psychological models. Acta Psychiatr Scand (2007) 1.32
Partial expiratory flow-volume curves in infancy: technical aspects. Bull Eur Physiopathol Respir (1986) 1.32
Cloning of the human oestrogen receptor cDNA. J Steroid Biochem (1986) 1.31
Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol (1998) 1.31
Should ICSI be the treatment of choice for all cases of in-vitro conception? Hum Reprod (2000) 1.31